The debate about psychologist prescribing continues.
You are here
P&T® Journal contents for August 2005
Letter to the Editor
Toward Safer Prescribing: History, Challenges, and Potential Solutions in Outpatient Medication Safety
Successful approaches to reducing errors will require system improvements rather than exhortations for prescribers to “try harder.”
The authors discuss the use of rosiglitazone (Avandia®) and pioglitazone (Actos®) for patients with type-2 diabetes.
The new Medicare prescription drug plan encourages beneficiaries to select generic over branded products.
Mr. Alexander summarizes presentations on androgen-suppressing therapies for men with prostate cancer and the associated risk of osteoporosis, the use of bone scans in prostate cancer, and genetic mutations as markers for selecting pharmacotherapy.
The authors discuss therapies for asthma, chronic obstructive pulmonary disease, pulmonary hypertension, and respiratory syncytial virus disease, as well as rimonabant as an aid in smoking cessation.